Scholarlink

<p>Radiotherapy remains a cornerstone treatment for head-and-neck cancer (HNC), yet resistance to radiation therapy significantly limits clinical outcomes. MicroRNAs (miRNAs) have emerged as promising regulators of radiosensitivity; however, the mechanisms by which miRNAs modulate radiosensitivity in HNC remain incompletely understood. In this study, we employed a multi-omics strategy integrating transcriptomic, clinical, and outcome data to investigate miRNA-associated radiosensitivity. Critically, we defined two distinct patient cohorts in the public dataset: one group received only radiotherapy, and the other did not receive radiotherapy. This stratification allowed us to conduct a unique comparative bioinformatics analysis, leading to the identification of miR-4776-5p as a candidate radiosensitizer. Elevated miR-4776-5p expression correlated with improved prognosis, specifically in patients receiving radiotherapy. Functional assays confirmed that miR-4776-5p sensitized FaDu HNC cells to radiation-induced DNA damage and impaired clonogenic survival. Mechanistic analyses demonstrated that miR-4776-5p modulates the cell cycle and DNA damage response pathways, enhancing tumor radiosensitivity. Furthermore, xenograft mouse models validated the radiosensitizing effects of miR-4776-5p in vivo, evidenced by significantly delayed tumor growth following irradiation. These findings highlight miR-4776-5p as a potential biomarker and therapeutic agent to improve radiotherapy efficacy in HNC, supporting further clinical exploration.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Integrative multi-omics and preclinical analyses identify miR-4776-5p as a prognostic radiosensitizer for patients undergoing radiotherapy for head-and-neck cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月28日

查看全文
  • Yo-Liang Lai,
  • Chun-Chieh Wang,
  • Kai-Wen Hsu,
  • Ching-Fang Yu,
  • Yung-Lun Lin,
  • Pei-Chun Shen,
  • Meng-Hsin Tsai,
  • Fang-Hsin Chen,
  • Wei-Chung Cheng

摘要

Radiotherapy remains a cornerstone treatment for head-and-neck cancer (HNC), yet resistance to radiation therapy significantly limits clinical outcomes. MicroRNAs (miRNAs) have emerged as promising regulators of radiosensitivity; however, the mechanisms by which miRNAs modulate radiosensitivity in HNC remain incompletely understood. In this study, we employed a multi-omics strategy integrating transcriptomic, clinical, and outcome data to investigate miRNA-associated radiosensitivity. Critically, we defined two distinct patient cohorts in the public dataset: one group received only radiotherapy, and the other did not receive radiotherapy. This stratification allowed us to conduct a unique comparative bioinformatics analysis, leading to the identification of miR-4776-5p as a candidate radiosensitizer. Elevated miR-4776-5p expression correlated with improved prognosis, specifically in patients receiving radiotherapy. Functional assays confirmed that miR-4776-5p sensitized FaDu HNC cells to radiation-induced DNA damage and impaired clonogenic survival. Mechanistic analyses demonstrated that miR-4776-5p modulates the cell cycle and DNA damage response pathways, enhancing tumor radiosensitivity. Furthermore, xenograft mouse models validated the radiosensitizing effects of miR-4776-5p in vivo, evidenced by significantly delayed tumor growth following irradiation. These findings highlight miR-4776-5p as a potential biomarker and therapeutic agent to improve radiotherapy efficacy in HNC, supporting further clinical exploration.